Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Drug Class Review: Triptans: Final Report Update 4 [Internet].

Helfand M, Peterson K.

Portland (OR): Oregon Health & Science University; 2009 Jun.

2.

Rational migraine management: optimising treatment with the triptans.

Millson DS.

Funct Neurol. 2000;15 Suppl 3:182-91. Review.

PMID:
11200789
3.

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

Ferrari MD, Goadsby PJ, Roon KI, Lipton RB.

Cephalalgia. 2002 Oct;22(8):633-58. Erratum in: Cephalalgia. 2003 Feb;23(1):71..

PMID:
12383060
4.

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.

Ferrari MD, Roon KI, Lipton RB, Goadsby PJ.

Lancet. 2001 Nov 17;358(9294):1668-75.

PMID:
11728541
5.

[Clinical use of triptans in the management of migraine].

Lantéri-Minet M.

CNS Drugs. 2006;20 Spec no.1:12-23. Review. French.

PMID:
16841523
6.

Triptans in pregnancy.

Soldin OP, Dahlin J, O'Mara DM.

Ther Drug Monit. 2008 Feb;30(1):5-9. doi: 10.1097/FTD.0b013e318162c89b. Review.

7.

Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.

Sheftell FD, Feleppa M, Tepper SJ, Volcy M, Rapoport AM, Bigal ME.

Headache. 2004 Jul-Aug;44(7):661-8.

PMID:
15209687
8.

Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.

Thorlund K, Mills EJ, Wu P, Ramos E, Chatterjee A, Druyts E, Goadsby PJ.

Cephalalgia. 2014 Apr;34(4):258-67. doi: 10.1177/0333102413508661. Epub 2013 Oct 9.

PMID:
24108308
9.

Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain.

Johnson DE, Rollema H, Schmidt AW, McHarg AD.

Eur J Pharmacol. 2001 Aug 17;425(3):203-10.

PMID:
11513839
10.

Drug Class Review on Triptans: Final Report Update 3 [Internet].

Helfand M, Peterson K.

Portland (OR): Oregon Health & Science University; 2005 Nov.

11.

Migraine pharmacotherapy with oral triptans: a rational approach to clinical management.

Millson DS, Tepper SJ, Rapoport AM.

Expert Opin Pharmacother. 2000 Mar;1(3):391-404. Review.

PMID:
11249525
12.

Sumatriptan: pharmacological basis and clinical results.

Dahlöf CG.

Curr Med Res Opin. 2001;17 Suppl 1:s35-45. Review.

PMID:
12463276
13.

The new triptans.

Gawel MJ.

Can J Clin Pharmacol. 1999 Autumn;6 Suppl A:20A-4A. Review.

PMID:
10494008
14.

Formulation Approaches of Triptans for Management of Migraine.

Kassem AA.

Curr Drug Deliv. 2016;13(6):882-98. Review.

PMID:
27109335
15.

Current and emerging second-generation triptans in acute migraine therapy: a comparative review.

Deleu D, Hanssens Y.

J Clin Pharmacol. 2000 Jul;40(7):687-700. Review.

PMID:
10883409
16.

Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study.

Solomon S, Frishberg B, Hu XH, Markson L, Berger M.

Clin Ther. 2001 Jun;23(6):886-900.

PMID:
11440288
17.

Safety profile of the triptans.

Tepper SJ, Millson D.

Expert Opin Drug Saf. 2003 Mar;2(2):123-32. Review.

PMID:
12904112
18.

Menstrual Migraine and Treatment Options: Review.

Maasumi K, Tepper SJ, Kriegler JS.

Headache. 2017 Feb;57(2):194-208. doi: 10.1111/head.12978. Epub 2016 Dec 2. Review.

PMID:
27910087
19.

Drugs for the acute treatment of migraine in children and adolescents.

Richer L, Billinghurst L, Linsdell MA, Russell K, Vandermeer B, Crumley ET, Durec T, Klassen TP, Hartling L.

Cochrane Database Syst Rev. 2016 Apr 19;4:CD005220. doi: 10.1002/14651858.CD005220.pub2. Review.

PMID:
27091010
20.

Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons.

Gerth WC, McCarroll KA, Santanello NC, Vandormael K, Zhang Q, Mannix LK.

Int J Clin Pract. 2001 Oct;55(8):552-6.

PMID:
11695077

Supplemental Content

Support Center